ArticleWorld journal of surgical oncology2026
Retrospective study on the magnetic resonance imaging integration rate of acellular dermal matrix and complications after breast-conserving surgery plus radiotherapy.
Article in World journal of surgical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBreast-conserving surgery (BCS) is increasingly preferred for early-stage breast cancer; however, conventional oncoplastic approaches may not adequately address large or irregular defects. Acellular dermal matrix (ADM), particularly paste-type formulations, offers a potential solution for volume replacement, though evidence regarding safety, integration, and imaging outcomes remains limited.
methodsThis retrospective review included 74 patients who underwent BCS with intraoperative paste-type ADM between June 2022 and August 2023. MRI and ultrasonography evaluated ADM integration and postoperative morphology, and complications were recorded. Stratified statistical analyses examined associations among imaging results, clinicopathologic characteristics, ADM volume, and outcomes.
resultsPaste-type ADM demonstrated safe integration with a low complication rate (4.1%) and no severe events such as infection or extrusion. MRI showed favorable integration grades (G0–G1) in over half of the patients. Ultrasonography identified three post-ADM morphologies: mass-like, cystic, and gap-type, which were associated with initial ADM volume and patient characteristics. No clinical or imaging variables predicted adverse outcomes, and minor complications were managed conservatively.
conclusionPaste-type ADM is a reliable, safe, and robust option for volume replacement in breast-conserving surgery, with favorable integration confirmed by MRI and ultrasonography. These findings support its broader use in oncoplastic breast surgery, improving reconstructive strategies and facilitating enhanced oncologic and aesthetic outcomes through multidisciplinary imaging surveillance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.